Prefilled Syringes Market by Purpose of Syringe (Specialty Prefilled Syringes, Therapeutic Prefilled Syringes and Cosmetic Prefilled Syringes), Therapeutic Area (Therapeutic Syringes - Blood Disorders, Infectious Diseases, Autoimmune Disorders, Oncologica

Prefilled Syringes Market by Purpose of Syringe (Specialty Prefilled Syringes, Therapeutic Prefilled Syringes and Cosmetic Prefilled Syringes), Therapeutic Area (Therapeutic Syringes - Blood Disorders, Infectious Diseases, Autoimmune Disorders, Oncological Disorders, Cardiovascular Disorders, Respiratory Disorders, Neurological Disorders, Metabolic Disorders, Ophthalmic Disorders, Orthopedic Disorders and Others), Type of Molecule (Therapeutic Syringes - Proteins, Antibodies, Peptides, Small Molecules, Vaccines and Cell Therapies), Type of Barrel Material (Glass Syringes and Plastic Syringes), Number of Barrel Chamber (Single Chamber Syringes and Dual Chamber Syringes), Type of Needle System (Staked Needle Syringes and Luer Syringes), Usability of Syringe (Disposable Syringes and Reusable Syringes), Type of Syringe (Conventional Syringes and Safety Syringes), Type of Packaging (Bulk Syringes and Nested Syringes) and Key Geographical Regions (North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America): Industry Trends and Global Forecasts, Till 2035

Prefilled Syringes Market: Overview

As per Roots Analysis, the global prefilled syringes market is estimated to grow from USD 3.02 billion in the current year to USD 4.97 billion by 2035, at a CAGR of 4.6% during the forecast period, till 2035.

The market sizing and opportunity analysis has been segmented across the following parameters:

Purpose of Syringe

• Specialty Prefilled Syringes
• Therapeutic Prefilled Syringes
• Cosmetic Prefilled Syringes

Therapeutic Area (Therapeutic Syringes)

• Blood Disorders
• Infectious Diseases
• Autoimmune Disorders
• Oncological Disorders
• Cardiovascular Disorders
• Respiratory Disorders
• Neurological Disorders
• Metabolic Disorders
• Ophthalmic Disorders
• Orthopedic Disorders
• Others

Type of Molecule (Therapeutic Syringes)

• Proteins
• Antibodies
• Peptides
• Small Molecules
• Vaccines
• Cell Therapies

Type of Barrel Material

• Glass Syringe
• Plastic Syringe

Number of Barrel Chamber

• Single Chamber Syringe
• Dual Chamber Syringe

Type of Needle System

• Staked Needle Syringe
• Luer Syringe

Usability of Syringe

• Disposable Syringe
• Reusable Syringe

Type of Syringe

• Conventional Syringe
• Safety Syringe

Type of Packaging

• Bulk Syringe
• Nested Syringe

Key Geographical Regions

• North America (US and Canada)
• Europe (Germany, France, Italy, Spain, UK, Rest of Europe)
• Asia-Pacific (Japan, India, China, Australia, South Korea, Rest of Asia Pacific)
• Middle East and North Africa
• Latin America

PREFILLED SYRINGES MARKET: GROWTH AND TRENDS

With the increasing prevalence of chronic diseases and the growing need to administer injectable medications on a frequent basis, there is a notable rise in preference for self-administration of drugs / therapeutics. According to a recent study, close to 133 million individuals annually suffer from one or more chronic disorders in the US alone and this number is likely to reach 170 million by 2030. As a result, a number of drug delivery devices that can be used for self-medication have been developed and introduced into the market. Examples include autoinjectors, large volume wearable injectors, pen injectors and prefilled syringes. It is worth highlighting that among the aforementioned devices, prefilled syringes are the most established range of products. In fact, given the advantages it offers over other traditional drug administration solutions, the applications of this drug packaging and delivery system have increased over the years. Moreover, with the increase in development of parenteral drugs, the consumption of prefilled syringes has tripled. The current demand for safer, easier to administer technologies along with the industry’s efforts to reduce costs and increase efficiency are expected to drive the growth of the prefilled syringes market in the future.

PREFILLED SYRINGES MARKET: KEY INSIGHTS

The report delves into the current state of the prefilled syringes market and identifies potential growth opportunities within the industry. Some key findings from the report include:

1. Presently, more than 120 prefilled syringes are available / being manufactured across the world; majority of the prefilled syringe manufacturers are based in Asia-Pacific.

2. Prefilled syringes are developed using different materials, needle systems and in different volume formats, to cater to the preferences and requirements of clients in the healthcare industry.

3. In pursuit of obtaining a competitive edge, companies are actively undertaking initiatives to integrate advanced features in their respective prefilled syringe portfolios.

4. Since 2019, more than 1,300 patents related to prefilled syringes and its related components have been filed / granted by various stakeholders to protect the intellectual property generated within this domain.

5. Several scientists, clinicians and industry veterans, affiliated to academic / medical / commercial organizations, are spearheading research related to prefilled syringes.

6. More than 170 prefilled syringe combination products are either commercially available or being evaluated for a variety of dosage forms.

7. Around 70% of the prefilled syringe combination products are currently in the later phases of development (Phase III and IV); the majority of these are being administered through the subcutaneous route.

8. Several big pharma players are actively carrying out initiatives to strengthen their injectable drug pipeline, across various therapeutic areas.

9. Close to 50 players are engaged in offering fill / finish services for prefilled syringes; majority of these players are based in Europe, followed by North America.

10. Identifying the driving factors (that fuel advancements) as well as barriers (that slow down the research progress) helps improve strategic planning and results in efficient operations in the prefilled syringes domain.

11. Owing to the growing demand for biologics and biosimilars (requiring precise dosing), and higher adoption of self-injection devices (in emergency conditions), the prefilled syringes market is likely to grow at a steady rate, till 2035.

12. Glass prefilled syringes capture majority share of this market; dual chamber prefilled syringes are anticipated to grow at a faster pace as compared to single chamber prefilled syringes.

13. The projected future opportunity for prefilled syringes market is likely to be well distributed in terms of usability of syringe, type of syringe, type of packaging and key geographical regions.

PREFILLED SYRINGES MARKET: KEY SEGMENTS

Currently, Specialty Syringes Segment Occupies the Largest Share of the Prefilled Syringes Market

Based on the purpose of the syringe, the market is segmented into specialty syringes, therapeutic syringes and cosmetic pre-filled syringes. At present, the specialty syringes segment holds the maximum share of the prefilled syringes market. It is worth highlighting that the prefilled syringes market for cosmetic pre-filled syringes is likely to grow at a relatively higher CAGR, during the forecast period.

Blood Disorders Segment Accounts for the Largest Share of the Prefilled Syringes Market

Based on the therapeutic area (therapeutic syringes), the market is segmented into blood disorders, infectious diseases, autoimmune disorders, oncological disorders, cardiovascular disorders, respiratory disorders, neurological disorders, metabolic disorders, ophthalmic disorders, orthopedic disorders and others. While blood disorders account for a relatively higher market share, it is worth highlighting that the oncological disorders segment is expected to witness substantial market growth in the coming years.

Protein Molecules are Likely to Dominate the Prefilled Syringes Market During the Forecast Period

Based on the type of molecule, the market is segmented into proteins, antibodies, peptides, small molecules, vaccines and cell therapies. At present, protein molecules hold the maximum share of the prefilled syringes market. It is worth highlighting that the prefilled syringes market for cell therapy is likely to grow at a relatively higher CAGR, during the forecast period.

Glass Material Accounts for the Largest Share of the Prefilled Syringes Market

Based on the type of barrel material, the market is segmented into glass syringes and plastic syringes. Currently, glass syringes hold the maximum share of the prefilled syringes market. It is worth highlighting that the prefilled syringes market for plastic syringes is likely to grow at a relatively higher CAGR, during the forecast period.

Currently, Single Chambered Segment Occupies the Largest Share of the Prefilled Syringes Market

Based on the number of barrel chambers, the market is segmented into single chambered and dual chambered. At present, glass syringes hold the maximum share of the prefilled syringes market. It is worth highlighting that the prefilled syringes market for dual chambered is likely to grow at a relatively higher CAGR, during the forecast period.

Luer Syringes Segment is the Fastest Growing Segment of the Prefilled Syringes Market During the Forecast Period

Based on the type of needle system, the market is segmented into staked needle syringes and luer syringes. At present, the staked needle syringe segment holds the maximum share of the prefilled syringes market. This can be attributed to the fact that these syringes have a low risk of needle detachment and are preferred in emergency medical conditions. It is worth highlighting that the prefilled syringes market for luer syringes is likely to grow at a relatively higher CAGR, during the forecast period.

Currently, Disposable Syringes Segment Occupies the Largest Share of the Prefilled Syringes Market

Based on the usability of syringes, the market is segmented into disposable syringes and reusable syringes. At present, disposable syringes hold maximum share of the prefilled syringes market. It is worth highlighting that the prefilled syringes market for reusable syringes is likely to grow at a relatively higher CAGR, during the forecast period.

Safety Prefilled Syringes Segment is Likely to Dominate the Prefilled Syringes Market During the Forecast Period

Based on the types of syringes, the market is segmented into conventional syringes and safety syringes. It is worth highlighting that, at present, safety prefilled syringes hold a larger share in the prefilled syringes market. This trend is likely to remain the same in the coming decade.

Currently, Nested Syringe Segment Occupies the Largest Share of the Prefilled Syringes Market

Based on the type of packaging, the market is segmented into nested syringe and bulk syringe. It is worth highlighting that, at present, nested syringe holds larger share in the prefilled syringes market. This trend is likely to remain the same in the coming decade.

Europe Accounts for the Largest Share of the Market

Based on key geographical regions, the market is segmented into North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America. It is worth highlighting that, over the years, the market in Asia-Pacific is expected to grow at a higher CAGR.

Example Players in the Prefilled Syringes Market

• Becton Dickinson
• Credence MedSystems
• Gerresheimer
• J.O.Pharma
• Medefil
• MedXL
• Mitsubishi Gas Chemical
• Nipro PharmaPackaging
• Novartis
• Pfizer
• SCHOTT
• Shandong Pharmaceutical Glass
• Shandong Weigao
• Shin Yan Sheno Precision Industrial
• Stevanato
• Taisei Kako
• Vetter Pharma
• West Pharmaceutical

Primary Research Overview

The opinions and insights presented in this study were influenced by discussions conducted with multiple stakeholders. The research report features detailed transcripts of interviews held with the following industry stakeholders:

• Founder and Chief Technology Officer, Oval Medical Technologies
• Chief Technical Officer, Intas Pharmaceuticals
• Senior Director and Former Director, West Pharmaceutical
• Head of R&D and Product Strategy, Lonstroff
• Senior Portfolio Director, IDEO
• Former Chief Commercial Officer, IDT Biologika
• Chief Executive Officer, A Small Medical Device Company

PREFILLED SYRINGES MARKET: RESEARCH COVERAGE

• Market Sizing and Opportunity Analysis: The report features an in-depth analysis of the prefilled syringes market, focusing on key market segments, including [A] purpose of syringe, [B] therapeutic area (therapeutic syringes), [C] type of molecule (therapeutic syringes), [D] type of barrel material, [E] number of barrel chamber, [F] type of needle system, [G] usability of syringe, [H] type of syringe, [I] type of packaging and [J] key geographical regions.
• Market Landscape: A comprehensive evaluation of the current prefilled syringes market, considering various parameters, such as [A] type of barrel fabrication material, [B] number of barrel chamber, [C] type of needle system and [D] volume of syringe. Further, the chapter provides a detailed analysis of prefilled syringe manufacturers, along with information on their [E] year of establishment, [F] company size (in terms of employee count), [G] location of headquarters, [H] location of their manufacturing facilities and [I] most active players (in terms of number of prefilled syringes manufactured).
• Product Competitiveness Analysis: A comprehensive competitive analysis of prefilled syringes, examining factors, such as [A] manufacturer strength and [B] product strength and [C] number of type of needle system.
• Company Profiles: In-depth profiles of key prefilled syringes manufacturers based in North America, Europe and Asia Pacific, focusing on [A] company overviews, [B] financial information (if available) [C] prefilled syringes portfolio, [D] recent developments and [D] an informed future outlook.
• Regulatory Landscape: A discussion on general regulatory guidelines for the approval of prefilled syringes, across different countries / geographical regions.
• Combination Products Analysis: A comprehensive examination of various combination products currently under evaluation or available as prefilled syringes, with a primary emphasis on injectable medications and vaccines. This analysis includes a thorough review of approved drugs, based on several relevant parameters, including [A] type of drug molecule, [B] year of approval, [C] region of approval, [D] route of administration and [E] target therapeutic area. Additionally, it includes analysis for products that are in clinical stage, for parameters such as [F] type of drug molecule, [G] phase of development, [H] route of administration and [I] target therapeutic area. The chapter also includes insights into the drug developers involved in developing these products, detailing their [J] year of establishment, [K] company size, [L] location of headquarters, and [M] manufacturing facility sites.
• Key Therapeutic Areas: An extensive discussion on the most commonly targeted therapeutic indications, including [A] information on the approved / marketed injectable drug products available for the treatment of such clinical conditions (across different target therapeutic areas) and [B] their respective biosimilars.
• Likely Drug Candidates Analysis: An in-depth analysis of marketed drugs / therapies that are likely to be available in prefilled syringe format in the near future. This analysis considers various relevant parameters, including [A] historical annual sales information, [B] type of drug molecule, [C] therapeutic area, [D] route of administration and [E] other available dosage forms.
• Big Pharma Analysis: A comprehensive examination of various initiatives focused on prefilled syringe combination products undertaken by major pharmaceutical companies. This analysis includes various relevant parameters, such as [A] number of prefilled syringe combination products (approved and under development), [B] target therapeutic area and [C] type of drug molecule.
• Recent Developments: A detailed analysis of recent developments in the prefilled syringes domain, based on relevant parameters such as [A] year of initiative, [B] type of initiative (partnerships and collaborations, expansions, funding and product launches), [C] geographical distribution and [D] most active players (in terms of number of recent developments).
• Patent Analysis: Detailed analysis of various patents filed / granted related to prefilled syringes based on [A] type of patent, [B] publication year, [C] application year, [D] type of applicant, [E] geographical location, [F] CPC symbols and [G] most active players (in terms of the number of patents filed / granted). It also includes a patent benchmarking analysis and a detailed valuation analysis.
• Key Opinion Leader Analysis: An in-depth examination that emphasizes the key opinion leaders (KOLs) within this field based on several relevant parameters, such as [A] role of KOL, [B] type of sponsor organization, [C] affiliated organization, [D] target indication and [E] geographical location of KOLs. In addition, the chapter highlights the most prominent KOLs, based on our proprietary scoring criteria.
• Specialty Prefilled Syringes: Detailed information on specialty syringes, specifically prefilled flush syringes, prefilled diluent systems, and prefilled syringes with contrast agents. Each type of specialty syringe is accompanied by [A] a brief overview and [B] information on various products available in the market, along with [C] their respective advantages.
• Technological Advances Related to Prefilled Syringes: A detailed description of the recent technological advancements in this domain and their applications. The chapter highlights the advancements in design technology and manufacturing of prefilled syringes, that have enabled pharmaceutical companies to market lyophilized drugs in dual chambered syringe systems. The chapter also highlights novel lubrication and sterilization technologies.
• Key Growth Drivers: A detailed discussion on the various factors that are likely to impact the prefilled syringes market, such as [A] increase in incidence of chronic diseases, [B] rising preference for self-administration of medications, [C] evolving patient landscape, [D] introduction and [D] growing adoption of biologics / biosimilars, [E] evolving pharmaceutical strategies, [F] initiatives focused on the prevention of needlestick injuries, and [G] the various potential applications of prefilled syringes.
• SWOT Analysis: A SWOT analysis, focusing on key drivers and challenges that are likely to impact the industry’s evolution. Further, it includes a Harvey ball analysis, highlighting the relative effect of each SWOT parameter on the overall industry.
• Additional Insight: The chapter discusses the growing concern associated with needlestick injuries and the various steps (including regional and global legislations) that have been taken to prevent these mishaps. In addition, it provides detailed information on the various safety features (add-on and integrated devices) installed in recent versions of prefilled syringes, and the companies engaged in development and manufacturing of such solutions.

KEY QUESTIONS ANSWERED IN THIS REPORT

• How many companies are currently engaged in this market?
• Which are the leading companies in this market?
• What factors are likely to influence the evolution of this market?
• What is the current and future market size?
• What is the CAGR of this market?
• How is the current and future market opportunity likely to be distributed across key market segments?

REASONS TO BUY THIS REPORT

• The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
• Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
• The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.

ADDITIONAL BENEFITS

• Complimentary PPT Insights Packs
• Complimentary Excel Data Packs for all Analytical Modules in the Report
• 10% Free Content Customization
• Detailed Report Walkthrough Session with Research Team
• Free Updated report if the report is 6-12 months old or older